Perrigo names new president, CEO and member of the board of directors
9 October 2018 -

Perrigo Company plc (NYSE: TASE: PRGO), a global provider of Quality Affordable Healthcare Products, announced yesterday that it has named Murray S Kessler as its new president, CEO and member of the board of directors, effective immediately.

Kessler most recently served as the chairman of the board of directors and CEO of Lorillard Tobacco Company. He spearheaded the company's expansion into new and emerging categories, growing Lorillard's market capitalisation from around USD9bn to around USD28bn during his tenure. Prior to joining Lorillard, he served as vice chair of Altria Inc and president and CEO of UST Inc. He originally joined UST in 2000 and was promoted to the role of president of the division within one year. In 2005, he was appointed COO of UST, and served as CEO from 2007 to 2009.

Chairman of the board of directors, Rolf Classon, said, 'We are excited to have Murray Kessler, a highly successful business executive, join Perrigo as its next CEO. Given the decision to separate the Rx pharmaceuticals business and pursue a consumer-focused strategy, the Board is looking forward to partnering with him to develop Perrigo's strategic plan. Murray joins Perrigo with more than 30 years of leadership experience in growing consumer products companies and managing businesses in a regulated environment. He has advanced corporate strategy through innovation, inorganic opportunities, and continuous portfolio improvement. We are confident that his track record in driving shareholder value and running highly successful businesses will advance Perrigo's consumer strategy and help the Company deliver on our commitments to consumers and customers.'